| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/05/2007 | US20070154391 Monoclonal antibodies; hybridomas; competitive binding |
| 07/05/2007 | US20070151928 Purification of immunoglobulins |
| 07/05/2007 | CA2634968A1 Method for detection of virulent strain of influenza type-a virus |
| 07/05/2007 | CA2634962A1 Vector for efficient selection and/or maturation of an antibody and uses thereof |
| 07/05/2007 | CA2634932A1 Treatment of neuroaids using inhibitors of glycogen synthase kinase (gsk)-3 |
| 07/05/2007 | CA2634262A1 Antibodies against interleukin-22 binding protein and its uses |
| 07/05/2007 | CA2634131A1 Protein formulations with reduced viscosity and uses thereof |
| 07/05/2007 | CA2634123A1 In vitro germinal centers |
| 07/05/2007 | CA2632799A1 Tgf-beta binding compositions |
| 07/05/2007 | CA2632519A1 Polishing steps used in multi-step protein purification processes |
| 07/04/2007 | EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers |
| 07/04/2007 | EP1803816A2 Mammalian cell surface antigens; related reagents |
| 07/04/2007 | EP1803814A1 Method of improving the antibody selection capacity in phage-display library |
| 07/04/2007 | EP1803809A2 Modulation of peroxisome proliferator-activated receptors |
| 07/04/2007 | EP1803807A2 Virulence genes, proteins, and their use |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803466A1 Treatment of chronic joint inflammation by an anti-CD3 antibody |
| 07/04/2007 | EP1802660A2 Methods of using death receptor ligands and cd20 antibodies |
| 07/04/2007 | EP1802659A2 Compositions and methods for treatment of non-hodgkin's lymphoma |
| 07/04/2007 | EP1802658A2 Chimeric and humanised monoclonal antibodies against interleukin-13 |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1802645A2 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof |
| 07/04/2007 | EP1802330A2 Validation of tssk family members and tsks as male contraceptive targets |
| 07/04/2007 | EP1613743A4 Fetal cell isolation and enrichment |
| 07/04/2007 | EP1336109B1 Kit and method for detecting the esm-1 protein |
| 07/04/2007 | EP1242823B1 Selecting library members capable of binding to epitopes |
| 07/04/2007 | EP1194560B1 Antigenic neisserial peptides |
| 07/04/2007 | EP1100811B1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 07/04/2007 | EP0948542B1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 07/04/2007 | EP0942750B1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 07/04/2007 | EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 07/04/2007 | CN1993468A Polypeptides having DNA polymerase activity |
| 07/04/2007 | CN1993379A Anti-il-13 antibodies, crystals of anti-il-13 antibodies and complexes comprising the same |
| 07/04/2007 | CN1993143A Method for treating multiple sclerosis |
| 07/04/2007 | CN1993142A Method for treating lupus |
| 07/04/2007 | CN1990504A Earthworm protein suppressing cancer cell accretion by road spectrum |
| 07/04/2007 | CN1324049C Human source anti SARS coronavirus gene engineering antibody |
| 07/03/2007 | US7238789 Sulfonated [8,9] benzophenoxazine dyes and the use of their labelled conjugates |
| 07/03/2007 | US7238788 Selectively binds to a human tau epitope comprising a phosphorylated tyrosine residue corresponding to the tyrosine residue |
| 07/03/2007 | US7238787 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/03/2007 | US7238786 For use in diagnosis and therapy |
| 07/03/2007 | US7238785 Antibody binding to glycoprotein; therapy, diagnosis of cancer |
| 07/03/2007 | US7238780 G-protein coupled receptor |
| 07/03/2007 | US7238777 Agents for adsorption and bridging for adenovirus |
| 07/03/2007 | US7238668 Exposing the lymphocytes to a peptide that binds to alpha 4 beta 1, consisting of three to twelve contiguous amino acid residues of the CS-1 region of fibronectin; suppression of the immune response |
| 07/03/2007 | US7238507 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 07/03/2007 | US7238489 Identification of sortase gene |
| 07/03/2007 | US7238488 Therapeutic and diagnostic applications of perlecan domain I splice variants |
| 07/03/2007 | US7238354 Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain |
| 07/03/2007 | US7238353 Antibodies that recognize hyperproliferative cells and methods of making and using same |
| 07/03/2007 | US7238352 Methods and compositions for modulating tumor growth |
| 07/03/2007 | US7238351 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it |
| 07/03/2007 | US7238338 Antioxidant, such as ethanol and/or ascorbic acid added to the radiolabeled compound during its preparation and/or storage, allows retention of biological or chemical activity of the radiohalogen-labeled compound such as nucleosides, nucleotides |
| 07/03/2007 | CA2361987C Goodpasture antigen binding protein |
| 07/03/2007 | CA2285918C Methods for concentrating ligands using magnetic particles |
| 07/03/2007 | CA2256413C Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 07/03/2007 | CA2243302C Anti-human vegf receptor f1t-1 monoclonal antibody |
| 07/03/2007 | CA2092567C Nt-4 neurotrophic factor |
| 06/28/2007 | WO2007073411A1 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/28/2007 | WO2007072866A1 Anti-ilt7 antibody |
| 06/28/2007 | WO2007072460A1 Sensing device and method for determination of the amount of target molecule in an analyte |
| 06/28/2007 | WO2007072070A1 New protein isoforms and uses thereof |
| 06/28/2007 | WO2007071992A1 Casein-like secreted protein |
| 06/28/2007 | WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | WO2007071449A1 Soluble gp130 molecule variants useful as a medicament |
| 06/28/2007 | WO2007071426A1 Pharmaceutical compositions with resistance to soluble cea |
| 06/28/2007 | WO2007071422A2 Pharmaceutical antibody compositions with resistance to soluble cea |
| 06/28/2007 | WO2007071250A2 Method for detection of l523s expression in biological samples |
| 06/28/2007 | WO2007071061A1 Methods for generating and screening fusion protein libraries and uses thereof |
| 06/28/2007 | WO2007071045A1 Catecholamine regulated protein |
| 06/28/2007 | WO2007071029A1 Hepatitis c virus ns2/3 assay |
| 06/28/2007 | WO2007070979A1 Chimeric antibodies with part new world primate binding regions |
| 06/28/2007 | WO2007070948A1 Anti-inflammatory dab |
| 06/28/2007 | WO2007070936A1 Zinc transporter |
| 06/28/2007 | WO2007053952B1 Platelet factor-4 (pf-4) analogs and their use |
| 06/28/2007 | WO2007051805A3 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 06/28/2007 | WO2007050607A3 Novel use of il-1beta compounds |
| 06/28/2007 | WO2007045476A3 Organic compounds |
| 06/28/2007 | WO2007044756A3 Monoclonal antibodies recognizing human ccr8 |
| 06/28/2007 | WO2007044031A3 Methods and compositions for detecting bacillus anthracis |
| 06/28/2007 | WO2007041645A3 Oxidized human bnp |
| 06/28/2007 | WO2007028144A3 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 06/28/2007 | WO2007027713A3 Trail receptor 2 polypeptides and antibodies |
| 06/28/2007 | WO2007019232A3 Immunoconjugate formulations |
| 06/28/2007 | WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza |
| 06/28/2007 | WO2007002069A3 Serum biomarkers for breast cancer |
| 06/28/2007 | WO2006132701A3 Methods and kits for regulation of microtubule assembly and dendrite growth and branching |
| 06/28/2007 | WO2006093923B1 Treatment of bone disorders |
| 06/28/2007 | WO2006090385A3 Protease inhibitors and method of screening thereof |
| 06/28/2007 | WO2006084075A3 Adam-9 modulators |
| 06/28/2007 | WO2006031986A3 Methods and compositions for diagnosing neoplastic disease |
| 06/28/2007 | WO2005113601A8 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 06/28/2007 | WO2005040194A3 Methods and compositions for pdgf-c activation and inhibition |
| 06/28/2007 | WO2005035732A3 Papp-a ligands |
| 06/28/2007 | WO2005028498A3 Kid3 and kid3 antibodies that bind thereto |
| 06/28/2007 | WO2002083919A3 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/28/2007 | US20070150984 Genetic sequences having methyltransferase activity and uses therefor |
| 06/28/2007 | US20070150978 Single nucleotide polymorphism (SNP) and repetitive element markers for use in characterizing phenotypic expression in plants |
| 06/28/2007 | US20070150972 Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |